Potency assay development uses DoE and QbD to improve accuracy, consistency, and regulatory readiness in biologics testing.

Screening automation bottlenecks in high-throughput screening arise from poor instrument integration, assay variability, data ...

Therapeutic antibodies are now the major class of successful protein drugs with many more in development to target a variety of major diseases. An important and desirable biological activity of most ...

An ELRIG webinar has explored how cell-based screening supports drug discovery, from early target validation to advanced ...

This poster was originally authored by John Vincent, Matthew Burnham, Gerrit Daubner, and Martin Main of the Medicines Discovery Catapult. It was presented at ELRIG Drug Discovery 2023. Methods to ...

In the ever-evolving landscape of biomedical research, the need for reliable, consistent, and ready-to-use cell models has never been more critical. ATCC, a leading provider of biological materials, ...

This article outlines the characteristics, advantages, and limitations of 96‑, 384‑, and 1536‑well plates for high-throughput ...